Schedule 13D ownership disclosure

Tevogen Bio Holdings Inc

Security class unavailable · CUSIP: 88165K101

Event date: 2024-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
71.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-007591
Form type
SC 13D
Filer
Saadi Ryan H.
CIK
CIK 2011728
Filed
Feb 22, 2024
Reporting period
Feb 14, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub